ADMA Biologics CEO Adam S. Grossman reports sale of $288,120 in common shares
ADMA•ADMA Biologics President and CEO Adam S. Grossman sold 21,000 common shares at $13.72 each on November 16, 2026, and exercised options to acquire 15,000 shares at $5.40 each.
1. Share transactions
Grossman’s direct beneficial ownership totaled 2,064,777 common shares following the transactions.




